Plasma Osteopontin Increases After Bariatric Surgery and Correlates with Markers of Bone Turnover But Not with Insulin Resistance
Homeostatic model assessment
N-terminal telopeptide
Osteopontin
Bone remodeling
DOI:
10.1210/jc.2007-2383
Publication Date:
2008-03-12T03:33:44Z
AUTHORS (11)
ABSTRACT
Osteopontin (OPN) is a multifunctional protein involved in bone metabolism, cardiovascular disease, diabetes, and obesity. OPN levels are elevated the plasma adipose tissue of obese subjects, decreased with diet-induced weight loss.We investigated effect bariatric surgery on concentrations morbidly patients.The study was performed at university hospital.We 40 patients aged 43.1 +/- 1.8 yr, scheduled to undergo surgery. Roux-en-Y gastric bypass (RYGB) 30 subjects (27 females, three males), laparoscopic adjustable banding (LAGB) 10 (eight two males).All were studied before 1 yr (10.3-14.8 months) after intervention.OPN, leptin, C-reactive protein, insulin, homeostatic model assessment insulin resistance index, calcium, 25-hydroxyvitamin D, C telopeptide, osteocalcin determined.Both procedures significantly reduced body weight, mass Plasma increased from 31.4 3.8 52.8 3.7 ng/ml RYGB (P < 0.001) 29.8 6.9 46.4 10.6 LAGB = 0.042). Preoperative correlated age, postoperative OPN. Postoperative telopeptide osteocalcin.One year LAGB, biomarkers turnover. Unlike other proinflammatory cytokines, does not normalize but increases further
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (38)
CITATIONS (54)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....